Drugs / Vitamin B Complex

Trials 4

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT03564678 May 2018 → Oct 2024 acute lymphoblastic leukemia, hyperbilirubinemia M.D. Anderson Cancer Center Terminated No outcome recorded Stop: Enrollment
Phase 31 trial
Phase 3 NCT04813471 Jan → Mar 2021 COVID-19 Lebanese American University Medical Center Unknown No outcome recorded
Phase 41 trial
Phase 4 NCT04893733 Sep 2020 → Dec 2021 acute kidney injury Caja Nacional de Salud Completed No outcome recorded
Phase not applicable1 trial
— NCT06857734 Mar 2025 → May 2026 overdue — Benha University Not yet recruiting No outcome recorded
Comparator or background therapy4 trials
Phase 3 NCT04189367 Background Jun 2020 → Jul 2022 burning mouth syndrome Chang Gung Memorial Hospital Unknown No outcome recorded
Phase 3 NCT03594240 Comparator Mar 2017 → Mar 2018 hyperglycemia, hyperhomocysteinemia Ain Shams University Completed No outcome recorded
Phase 3 NCT01283646 Comparator Oct 2011 → May 2012 — EMS Completed No outcome recorded
— NCT03601494 Comparator Feb → Nov 2017 chronic pain syndrome, diabetic neuropathy Assiut University Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 8 sources stand behind the page.

FieldValueCited text
Known as Vitamin B Complex “Nutritional supplement: vitamin B12, folic acid, iron, zinc, vitamin B complex depending on the hematic deficiency, for 12 weeks” NCT04189367 ↗
7

“vitamin B complex, α lipoic acid, selective serotonin reuptake inhibitor (SSRI)” NCT03601494 ↗

“Vitamin B complex (Becozyme) 1 ampoule IV daily” NCT04813471 ↗

NCT04893733 ↗

NCT03564678 ↗

NCT01283646 ↗

NCT03594240 ↗

NCT06857734 ↗

Known as Becozyme “Vitamin B complex (Becozyme) 1 ampoule IV daily” NCT04813471 ↗
Known as Neurorubine TM -Forte Lactab TM “Vitamin B complex tablets (Neurorubine TM -Forte Lactab TM) once daily” NCT03594240 ↗
Route Oral “Given PO” NCT03564678 ↗